Symbol="GRTX"
AssetType="Common Stock"
Name="Galera Therapeutics Inc"
Description="Galera Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapies for the transformation of radiation therapy in cancer. The company is headquartered in Malvern, Pennsylvania."
CIK="1563577"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="PHARMACEUTICAL PREPARATIONS"
Address="2 WEST LIBERTY BLVD #100, MALVERN, PA, US"
FiscalYearEnd="December"
LatestQuarter="2023-03-31"
MarketCapitalization="123143000"
EBITDA="-51850000"
PERatio="None"
PEGRatio="None"
BookValue="-2.275"
DividendPerShare="0"
DividendYield="0"
EPS="-2.32"
RevenuePerShareTTM="0"
ProfitMargin="0"
OperatingMarginTTM="0"
ReturnOnAssetsTTM="-0.496"
ReturnOnEquityTTM="-10.63"
RevenueTTM="0"
GrossProfitTTM="0"
DilutedEPSTTM="-2.32"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="0"
AnalystTargetPrice="7.75"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="-"
PriceToBookRatio="29.39"
EVToRevenue="-"
EVToEBITDA="-0.0899"
Beta="1.77"
num_52WeekHigh="3.59"
num_52WeekLow="1.12"
num_50DayMovingAverage="3.065"
num_200DayMovingAverage="2.219"
SharesOutstanding="42906800"
DividendDate="None"
ExDividendDate="None"
symbol="GRTX"
open="2.92"
high="2.92"
low="2.82"
price="2.87"
volume="490697.00"
latest_trading_day="2023-07-11"
previous_close="2.93"
change="-0.06"
change_percent="-2.0478%"
aroon_positive_momentum_days="0"
aroon_negative_momentum_days="7"
trend_strength="Absent or Weak Trend"
buying_signal="High Volatility / Hold Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="93"
Volume_recent_avg="760043"
Change_recent_avg="-0.01"
Delta_recent_avg="0.2"
Variance_recent_avg="0.1"
Change_ratio_recent_avg="-0.2"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="negative"
Aroon_change="FALSE"
Aroon_momentum_positive="93"
Aroon_momentum_negative="7"
image_negative_thumbnail_id_1="154"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0022.jpeg"
image_negative_thumbnail_id_2="1164"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0198.jpeg"
image_neutral_thumbnail_id_1="543"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0056.jpeg"
image_neutral_thumbnail_id_2="560"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0039.jpeg"
image_positive_thumbnail_id_1="660"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0048.jpeg"
image_positive_thumbnail_id_2="1013"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0175.jpeg"
image_professor_thumbnail_id_1="1203"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0037.jpeg"
image_professor_thumbnail_id_2="1176"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0010.jpeg"
